Influenza-attributable burden in United Kingdom primary care

D M Fleming, R J Taylor, F Haguinet, C Schuck-Paim, J Logie, D J Webb, R L Lustig, G Matias, D M Fleming, R J Taylor, F Haguinet, C Schuck-Paim, J Logie, D J Webb, R L Lustig, G Matias

Abstract

Influenza is rarely laboratory-confirmed and the outpatient influenza burden is rarely studied due to a lack of suitable data. We used the Clinical Practice Research Datalink (CPRD) and surveillance data from Public Health England in a linear regression model to assess the number of persons consulting UK general practitioners (GP episodes) for respiratory illness, otitis media and antibiotic prescriptions attributable to influenza during 14 seasons, 1995-2009. In CPRD we ascertained influenza vaccination status in each season and risk status (conditions associated with severe influenza outcomes). Seasonal mean estimates of influenza-attributable GP episodes in the UK were 857 996 for respiratory disease including 68 777 for otitis media, with wide inter-seasonal variability. In an average season, 2·4%/0·5% of children aged <5 years and 1·3%/0·1% of seniors aged ⩾75 years had a GP episode for respiratory illness attributed to influenza A/B. Two-thirds of influenza-attributable GP episodes were estimated to result in prescription of antibiotics. These estimates are substantially greater than those derived from clinically reported influenza-like illness in surveillance programmes. Because health service costs of influenza are largely borne in general practice, these are important findings for cost-benefit assessment of influenza vaccination programmes.

Trial registration: ClinicalTrials.gov NCT01520935.

Keywords: Epidemiology; GP surveillance systems; infectious disease; influenza; influenza vaccines.

Figures

Fig. 1.
Fig. 1.
Attribution modelling showing excess GP episodes attributable to influenza A and B and respiratory syncytial virus (RSV) in children aged 5–17 years. The pattern was observed to be the same for other age groups. ‘All other’ refers to GP episodes not attributable to influenza or RSV. The denominator is the UK population.
Fig. 2.
Fig. 2.
Seasonal rates (with 95% confidence intervals) of GP episodes for respiratory disease (broadly defined) attributable to influenza A, influenza B and respiratory syncytial virus (RSV).
Fig. 3.
Fig. 3.
The percentage of the estimated burdens for several outcomes attributed to influenza A and influenza B by five age groups (mean across seasons). The total number of GP episodes for each outcome was: respiratory disease (broadly defined) (n = 857 996), bronchitis and bronchiolitis (n = 248 727), influenza-like illness (n = 265 123), pneumonia and influenza (n = 197 769), otitis media (n = 68 777), antibiotic use (n = 604 042).

References

    1. Fleming DM, Elliot AJ. Lessons from 40 years’ surveillance of influenza in England and Wales. Epidemiology and Infection 2008; 136: 866–875.
    1. Fleming DM. The contribution of influenza to combined acute respiratory infections, hospital admissions, and deaths in winter. Communicable Disease and Public Health 2000; 3: 32–38.
    1. Nicholson KG. Chapter 19 In: Nicholson KG, Webster RG, Hay AJ, eds. Textbook of Influenza. Oxford: Blackwell Sciences, 1998, pp. 221–223.
    1. Miller E, et al. Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study. Lancet 2010; 375: 1100–1108.
    1. Fleming DM, Zambon M, Bartelds AI. Population estimates of persons presenting to general practitioners with influenza-like illness, 1987–96: a study of the demography of influenza-like illness in sentinel practice networks in England and Wales, and in The Netherlands. Epidemiology and Infection 2000; 124: 245–253.
    1. Fleming D, Harcourt S, Smith G. Influenza and adult hospital admissions for respiratory conditions in England 1989–2001. Communicable Disease and Public Health 2003; 6: 231–237.
    1. Glezen WP, et al. Impact of respiratory virus infections on persons with chronic underlying conditions. Journal of the American Medical Association 2000; 283: 499–505.
    1. Molinari N-AM, et al. The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine 2007; 25: 5086–5096.
    1. Fleming DM, et al. The duration and magnitude of influenza epidemics: a study of surveillance data from sentinel general practices in England, Wales and the Netherlands. European Journal of Epidemiology 1999; 15: 467–473.
    1. Elliot AJ, Cross KW, Fleming DM. Acute respiratory infections and winter pressures on hospital admissions in England and Wales 1990–2005. Journal of Public Health (Oxford) 2008; 30: 91–98.
    1. Thompson WW, et al. Mortality associated with influenza and respiratory syncytial virus in the United States. Journal of the American Medical Association 2003; 289: 179–186.
    1. Thompson WW, et al. Influenza-associated hospitalizations in the United States. Journal of the American Medical Association 2004; 292: 1333–1340.
    1. Pitman RJ, et al. Assessing the burden of influenza and other respiratory infections in England and Wales. Journal of Infection 2007; 54: 530–538.
    1. Hardelid P, Pebody R, Andrews N. Mortality caused by influenza and respiratory syncytial virus by age group in England and Wales 1999–2010. Influenza and Other Respiratory Viruses 2013; 7: 35–45.
    1. Zambon MC, et al. Contribution of influenza and respiratory syncytial virus to community cases of influenza-like illness: an observational study. Lancet 2001; 358: 1410–1416.
    1. Williams T et al. Recent advances in the utility and use of the General Practice Research Database as an example of a UK Primary Care Data resource. Therapeutic Advances in Drug Safety 2013; 3: 89–99.
    1. Pebody RG, et al. Influenza vaccination coverage in England, 2000–2008. Eurosurveillance 2008; 13: 19074.
    1. The Flu Immunisation Programme 2012/13 – Publications – (). Accessed 31 October 2013.
    1. Walley T, Mantgani A. The UK General Practice Research Database. Lancet 1997; 350: 1097–1099.
    1. Office of National Statistics. Taxonomy, 2010. (). Accessed 17 December 2013.
    1. Sullivan KM, Monto AS, Longini IM. Jr Estimates of the US health impact of influenza. American Journal of Public Health 1993; 83: 1712–1716.
    1. Schanzer DL, Schwartz B. Impact of seasonal and pandemic influenza on emergency department visits, 2003–2010, Ontario, Canada. Academic Emergency Medicine 2013; 20: 388–397.
    1. Serfling RE. Methods for current statistical analysis of excess pneumonia-influenza deaths. Public Health Report 1963; 78: 494–506.
    1. Matias G, et al. Estimates of mortality attributable to influenza and RSV in the United States during 1997–2009 by influenza type or subtype, age, cause of death, and risk status. Influenza and Other Respiratory Viruses 2014; 8: 507–515.
    1. Zhou H, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993–2008. Clinical Infectious Diseases 2012; 54: 1427–1436.
    1. Thompson WW, et al. Time-series analyses of count data to estimate the burden of seasonal infectious diseases. Epidemiology 2012; 23: 839–842.
    1. Yang L, et al. Validation of statistical models for estimating hospitalization associated with influenza and other respiratory viruses. PLoS ONE 2011; 6: .
    1. Gay NJ, et al. Estimating deaths due to influenza and respiratory syncytial virus. Journal of the American Medical Association 2003; 289: 2499.
    1. Goldstein E, et al. Improving the estimation of influenza-related mortality over a seasonal baseline. Epidemiology 2012; 23: 829–838.
    1. Christenson B, et al. Additive preventive effect of influenza and pneumococcal vaccines in elderly persons. European Respiratory Journal 2004; 23: 363–368.
    1. Cocoros NM, et al. Obesity as a risk factor for severe influenza-like illness. Influenza and Other Respiratory Viruses 2014; 8: 25–32.
    1. Mertz D, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. British Medical Journal 2013; 347: f5061.
    1. Heikkinen T, et al. Burden of influenza in children in the community. Journal of Infectious Disease 2004; 190: 1369–1373.
    1. Mulpuru S, et al. Influenza infection screening tools fail to accurately predict influenza status for patients during pandemic H1N1 influenza season. Canadian Respiratory Journal 2013; 20: e55–59.
    1. Michiels B, et al. Clinical prediction rules combining signs, symptoms and epidemiological context to distinguish influenza from influenza-like illnesses in primary care: a cross sectional study. BMC Family Practice 2011; 12: 4.
    1. Hawker JI, et al. Trends in antibiotic prescribing in primary care for clinical syndromes subject to national recommendations to reduce antibiotic resistance, UK 1995–2011: analysis of a large database of primary care consultations. Journal of Antimicrobial Chemotherapy 2014; 69: 3423–3430.
    1. Heikkinen T, et al. Effectiveness of intranasal live attenuated influenza vaccine against all-cause acute otitis media in children. Pediatric Infectious Disease Journal. 2013; 32: 669–674.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다